Studies heart and blood pressure in people born after high-blood-pressure pregnancies
Studies why young adults born to hypertensive pregnancies may face higher heart risk.
Plain-language title generated from the registry record
Registry title: Cardiovascular Longitudinal ALSPAC Research Investigations Following Hypertensive Pregnancy in Young Adulthood
Key facts
- Where
- Oxford, United KingdomSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 40 years old?
Source: NCT05683093, who can take part
Where in United Kingdom
- University of OxfordOxford, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Oxford
- Trial code
- NCT05683093
- Record updated
- 12 January 2023
- Original description
The purpose of this study is to understand more about why young people who were born to a hypertensive pregnancy may have increased risk of high blood pressure and are often at increased risk of heart and blood vessel disease later in life.Read full original descriptionShow less
Cardiovascular Longitudinal the Avon Longitudinal Study of Parents and Children (ALSPAC) Research Investigations Following Hypertensive Pregnancy in Young Adulthood
The purpose of this study is to understand more about why young people who were born to a hypertensive pregnancy may have increased risk of high blood pressure and are often at increased risk of heart and blood vessel disease later in life.
Inclusion: Participant is willing and able to give informed consent for participation in the study; Male or female, aged 30 to 40 years at time of enrolment; Participant previously took part in the ALSPAC study; Able (in the investigator's opinion) and willing to comply with all study requirements; Adequate understanding of verbal and written English.
Exclusion: Planning to donate blood within two weeks prior to study visit 1; Any significant disease or disorder which, in the opinion of the investigator, might influence the participant's ability to participate in the study; Evidence of congenital heart disease or significant chronic disease relevant to cardiovascular or metabolic status; For exclusion of MRI component only:; Pregnant or lactating when they are due to attend for study visit 1; Less than six months postpartum; Unsuitable for MRI based on participant screening; the participant may still be included in other parts of the study.